1 |
Bone marrow stromal cells (MSCs) |
Cranial defects |
Three‐dimensional computerized tomography (CT) scan revealed an almost complete repair of the defect of the experimental group at 18 weeks. This study may provide insight for the future clinical repair of cranial defect |
The objective of this study was to investigate the potential of using autologous MSCs to repair cranial bone defects by a tissue‐engineering approach |
112
|
2 |
Dental mesenchymal cell |
Mandibular defects |
This pilot study supports the feasibility of tissue‐engineering approaches for coordinated autologous tooth and mandible reconstruction, and provides a basis for future improvement of this technique for eventual clinical use in humans |
Investigated simultaneous mandibular and tooth reconstruction using a Yucatan minipig model |
113
|
3 |
Genetically engineered bone marrow‐derived mesenchymal stem cells overexpressing hypoxia‐inducible factor‐1α |
Calvarial defects in rats |
HIF‐1α‐overexpressing BMSCs dramatically improved the repair of critical‐sized calvarial defects, including increased bone volume, bone mineral density, blood vessel number, and blood vessel area in vivo |
The hypothesis that HIF‐1α gene therapy could be used to promote the repair of critical‐sized bone defects |
114
|
4 |
Bone marrow‐derived mesenchymal stem cells (BMSCs) genetically engineered transient expression of osteogenic/angiogenic factors and growth factor expression |
Calvarial bone healing |
BMSCs accelerated the bone remodeling and regenerated the bone through the natural intramembranous pathway |
Augmented healing of critical‐size calvarial defects by baculovirus‐engineered MSCs that persistently express growth factors |
115
|
5 |
Amniotic epithelial cells |
Maxillary sinus |
The obtained data suggest that scaffold integration and bone deposition are positively influenced by allotransplantated oAEC |
The bone regenerative property of an emerging source of progenitor cells, the amniotic epithelial cells (AEC), loaded on a calcium‐phosphate synthetic bone substitute, made by direct rapid prototyping (rPT) technique, was evaluated in an animal study |
107
|
6 |
Human umbilical cord mesenchymal stem cells |
Rat cranial defects |
hUCMSC and hBMSC groups generally had statistically similar bone mineral density, new bone amount and vessel density |
hUCMSC and hBMSC seeding on macroporous calcium phosphate cement (CPC), and to compare their bone regeneration in critical‐sized cranial defects in rats |
116
|
7 |
Amniotic fluid mesenchymal cells engineered on MgHA/collagen‐based scaffold |
Sinus augmentation |
The osteoinductive effect of a biomimetic commercial scaffold may be significantly improved by the presence of ovine AFMC |
To evaluate whether commercial magnesium‐enriched hydroxyapatite (MgHA)/collagen‐based scaffold engineered with ovine amniotic fluid mesenchymal cells (oAFMC) could improve the bone regeneration process in vivo |
117
|